Company / Interest Expense
Oncology Institute, Inc. Interest Expense History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-$4.1M
FY2023
5-year range
-$4.1M / $347.0K
FY2021-FY2023
Trend
-1175.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense changed -1176% YoY in FY2023, a notable deviation from the 2-year average annual change of -684%.
Based on SEC 10-K filings.
-$4M in FY2023.
Improved from $347,000 to -$4M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense decreased 1175.6% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$4.1M | -1175.6% |
| FY2022 | -$320.0K | -192.2% |
| FY2021 | $347.0K | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026